{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:05:10Z","timestamp":1795007110594,"version":"4.9.1"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Renal failure is predictive of mortality in the early postliver-transplantation period and calcineurin inhibitors toxicity is a main challenge. Our aim is to assess the impact of longitudinal tacrolimus exposure (TLE) and other variables on chronic kidney disease (CKD)-free 1-year-survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>Retrospective data of consecutive patients transplanted between 2011 and 2016 and treated with tacrolimus were collected. TLE and all relevant pre- and post-liver transplantation (LT) predictive factors of CKD were tested and included in a time-to-event model. CKD was defined by repeated estimated glomerular filtration rate (eGFR) values below 60 mL\/min\/1.73m<jats:sup>2<\/jats:sup> at least for the last 3 months before M12 post-LT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Data from 180 patients were analyzed. CKD-free survival was 74.5% and was not associated with TLE. Pre-LT acute kidney injury (AKI) and eGFR at 1-month post-LT (eGFR<jats:sub>M1<\/jats:sub>) &lt;60 mL\/min\/1.73m<jats:sup>2<\/jats:sup> were significant predictors of CKD. By distinguishing 2 situations within AKI (ie, with or without hepatorenal syndrome [HRS]), only HRS-AKI remained associated to CKD. HRS-AKI and eGFR<jats:sub>M1<\/jats:sub> &lt;60 mL\/min\/1.73m<jats:sup>2<\/jats:sup> increased the risk of CKD (hazard ratio, 2.5; 95% confidence interval, 1.2-4.9; hazard ratio, 4.8; 95% confidence interval, 2.6-8.8, respectively).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>In our study, TLE, unlike HRS-AKI and eGFR<jats:sub>M1<\/jats:sub>, was not predictive of CKD-free survival at 1-year post-LT. Our results once again question the reversibility of HRS-AKI.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000003384","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T21:01:33Z","timestamp":1594069293000},"page":"1585-1594","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of Longitudinal Exposure to Tacrolimus as a Risk Factor of Chronic Kidney Disease Occurrence Within the First-year Post-Liver Transplantation"],"prefix":"10.1097","volume":"105","author":[{"given":"Pauline","family":"Maurel","sequence":"first","affiliation":[{"name":"Hepatology and Gastroenterology Unit, University Hospital of Limoges, Limoges, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Pr\u00e9maud","sequence":"additional","affiliation":[{"name":"INSERM U1248, University of Limoges, F-87000, Limoges, France."},{"name":"FHU SUPORT: University Hospital Federation SUrvival oPtimization in ORgan Transplantation, Limoges, F-87000, Tours, F-30000, Poitiers F-86000, Orl\u00e9ans F-45000, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Carrier","sequence":"additional","affiliation":[{"name":"Hepatology and Gastroenterology Unit, University Hospital of Limoges, Limoges, France."},{"name":"INSERM U1248, University of Limoges, F-87000, Limoges, France."},{"name":"FHU SUPORT: University Hospital Federation SUrvival oPtimization in ORgan Transplantation, Limoges, F-87000, Tours, F-30000, Poitiers F-86000, Orl\u00e9ans F-45000, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Essig","sequence":"additional","affiliation":[{"name":"INSERM U1248, University of Limoges, F-87000, Limoges, France."},{"name":"FHU SUPORT: University Hospital Federation SUrvival oPtimization in ORgan Transplantation, Limoges, F-87000, Tours, F-30000, Poitiers F-86000, Orl\u00e9ans F-45000, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Barbier","sequence":"additional","affiliation":[{"name":"FHU SUPORT: University Hospital Federation SUrvival oPtimization in ORgan Transplantation, Limoges, F-87000, Tours, F-30000, Poitiers F-86000, Orl\u00e9ans F-45000, France."},{"name":"Department of Digestive Surgery and Liver Transplantation, Trousseau University Hospital, Chambray-l\u00e8s-Tours, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Rousseau","sequence":"additional","affiliation":[{"name":"INSERM U1248, University of Limoges, F-87000, Limoges, France."},{"name":"FHU SUPORT: University Hospital Federation SUrvival oPtimization in ORgan Transplantation, Limoges, F-87000, Tours, F-30000, Poitiers F-86000, Orl\u00e9ans F-45000, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Silvain","sequence":"additional","affiliation":[{"name":"FHU SUPORT: University Hospital Federation SUrvival oPtimization in ORgan Transplantation, Limoges, F-87000, Tours, F-30000, Poitiers F-86000, Orl\u00e9ans F-45000, France."},{"name":"Hepatology and Gastroenterology Unit, University Hospital of Poitiers, Poitiers, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Causse","sequence":"additional","affiliation":[{"name":"FHU SUPORT: University Hospital Federation SUrvival oPtimization in ORgan Transplantation, Limoges, F-87000, Tours, F-30000, Poitiers F-86000, Orl\u00e9ans F-45000, France."},{"name":"Hepatology and Gastroenterology Unit, Regional Hospital Center of Orl\u00e9ans, Orl\u00e9ans La Source, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyne","family":"Debette-Gratien","sequence":"additional","affiliation":[{"name":"Hepatology and Gastroenterology Unit, University Hospital of Limoges, Limoges, France."},{"name":"INSERM U1248, University of Limoges, F-87000, Limoges, France."},{"name":"FHU SUPORT: University Hospital Federation SUrvival oPtimization in ORgan Transplantation, Limoges, F-87000, Tours, F-30000, Poitiers F-86000, Orl\u00e9ans F-45000, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9mie","family":"Jacques","sequence":"additional","affiliation":[{"name":"Hepatology and Gastroenterology Unit, University Hospital of Limoges, Limoges, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Marquet","sequence":"additional","affiliation":[{"name":"INSERM U1248, University of Limoges, F-87000, Limoges, France."},{"name":"FHU SUPORT: University Hospital Federation SUrvival oPtimization in ORgan Transplantation, Limoges, F-87000, Tours, F-30000, Poitiers F-86000, Orl\u00e9ans F-45000, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephrem","family":"Salam\u00e9","sequence":"additional","affiliation":[{"name":"FHU SUPORT: University Hospital Federation SUrvival oPtimization in ORgan Transplantation, Limoges, F-87000, Tours, F-30000, Poitiers F-86000, Orl\u00e9ans F-45000, France."},{"name":"Department of Digestive Surgery and Liver Transplantation, Trousseau University Hospital, Chambray-l\u00e8s-Tours, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Loustaud-Ratti","sequence":"additional","affiliation":[{"name":"Hepatology and Gastroenterology Unit, University Hospital of Limoges, Limoges, France."},{"name":"INSERM U1248, University of Limoges, F-87000, Limoges, France."},{"name":"FHU SUPORT: University Hospital Federation SUrvival oPtimization in ORgan Transplantation, Limoges, F-87000, Tours, F-30000, Poitiers F-86000, Orl\u00e9ans F-45000, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/TP.0000000000002305","article-title":"Acute kidney injury after liver transplantation.","volume":"102","author":"Durand","year":"2018","journal-title":"Transplantation"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ.","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"150","DOI":"10.5414\/CNP75150","article-title":"Chronic kidney disease after orthotopic liver transplantation in recipients receiving tacrolimus.","volume":"75","author":"Garces","year":"2011","journal-title":"Clin Nephrol"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jhep.2010.12.001","article-title":"Immunosuppression in liver transplant recipients with renal impairment.","volume":"54","author":"Duvoux","year":"2011","journal-title":"J Hepatol"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.semnephrol.2007.03.010","article-title":"Renal disease in recipients of nonrenal solid organ transplantation.","volume":"27","author":"Ojo","year":"2007","journal-title":"Semin Nephrol"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2015.10.006","article-title":"Electronic address: easloffice@easloffice.eu. EASL clinical practice guidelines: liver transplantation.","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"R7-20250604","first-page":"1","article-title":"Variations in practice to therapeutic monitoring of tacrolimus following primary adult liver transplantation.","volume":"7","author":"Dasari","year":"2016","journal-title":"Int J Organ Transplant Med"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/00912700122010429","article-title":"Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients.","volume":"41","author":"Venkataramanan","year":"2001","journal-title":"J Clin Pharmacol"},{"issue":"Suppl 3","key":"R9-20250604","first-page":"S1","article-title":"Present state of immunosuppressive therapy in liver transplant recipients.","volume":"17","author":"Wiesner","year":"2011","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1432-2277.2008.00796.x","article-title":"Calcineurin inhibitor minimization protocols in liver transplantation.","volume":"22","author":"Farkas","year":"2009","journal-title":"Transpl Int"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/FTD.0b013e31819c6a37","article-title":"Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay.","volume":"31","author":"Wallemacq","year":"2009","journal-title":"Ther Drug Monit"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.phrs.2013.03.009","article-title":"Impact of longitudinal exposure to mycophenolic acid on acute rejection in renal-transplant recipients using a joint modeling approach.","volume":"72","author":"Daher Abdi","year":"2013","journal-title":"Pharmacol Res"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/clpt.2014.140","article-title":"Exposure to mycophenolic acid better predicts immunosuppressive efficacy than exposure to calcineurin inhibitors in renal transplant patients.","volume":"96","author":"Daher Abdi","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1111\/j.1600-6143.2012.04140.x","article-title":"Tacrolimus trough levels, rejection and renal impairment in liver transplantation: a systematic review and meta-analysis.","volume":"12","author":"Rodr\u00edguez-Per\u00e1lvarez","year":"2012","journal-title":"Am J Transplant"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report.","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther Drug Monit"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.trre.2018.04.001","article-title":"Identifying risk profiles in liver transplant candidates and implications for induction immunosuppression.","volume":"32","author":"Cillo","year":"2018","journal-title":"Transplant Rev (Orlando)"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites.","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jhep.2016.10.024","article-title":"New diagnostic criteria and management of acute kidney injury.","volume":"66","author":"Wong","year":"2017","journal-title":"J Hepatol"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis.","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2165\/11318080-000000000-00000","article-title":"Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients.","volume":"48","author":"Benkali","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/gut.2010.236133","article-title":"Working party proposal for a revised classification system of renal dysfunction in patients with cirrhosis.","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1214\/08-AOAS169","article-title":"Random survival forests.","volume":"2","author":"Ishwaran","year":"2008","journal-title":"Ann Appl Stat"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCOUTCOMES.110.939371","article-title":"Identifying important risk factors for survival in patient with systolic heart failure using random survival forests.","volume":"4","author":"Hsich","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/sam.10103","article-title":"Random survival forests for high-dimensional data.","volume":"4","author":"Ishwaran","year":"2011","journal-title":"Stat Anal Data Min ASA Data Sci J"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/SLA.0b013e3182365081","article-title":"Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era.","volume":"254","author":"Dutkowski","year":"2011","journal-title":"Ann Surg"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0169-2607(98)00098-4","article-title":"A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models.","volume":"59","author":"Parke","year":"1999","journal-title":"Comput Methods Programs Biomed"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1038\/psp.2013.24","article-title":"Modeling and simulation workbench for NONMEM: tutorial on pirana, PsN, and Xpose.","volume":"2","author":"Keizer","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR).","volume":"57","author":"Adam","year":"2012","journal-title":"J Hepatol"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1399-0012.2005.00447.x","article-title":"Long-term renal function after liver transplantation is related to calcineurin inhibitors blood levels.","volume":"20","author":"Morard","year":"2006","journal-title":"Clin Transplant"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity.","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1002\/lt.23750","article-title":"Is disease recurrence still relevant to graft survival?","volume":"19","author":"Trotter","year":"2013","journal-title":"Liver Transpl"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-6143.2008.02493.x","article-title":"Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the \u2018ReSpECT\u2019 study.","volume":"9","author":"Neuberger","year":"2009","journal-title":"Am J Transplant"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1111\/ajt.14010","article-title":"What\u2019s hot, what\u2019s new from the 2016 American Transplant Congress.","volume":"16","author":"Levitsky","year":"2016","journal-title":"Am J Transplant"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.transproceed.2012.03.034","article-title":"The 4-week serum creatinine level predicts long-term renal dysfunction after adult living donor liver transplantation.","volume":"44","author":"Lin","year":"2012","journal-title":"Transplant Proc"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1093\/ndt\/gfq093","article-title":"Risk factors for consequent kidney impairment and differential impact of liver transplantation on renal function.","volume":"25","author":"Lee","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1093\/ndt\/gfl247","article-title":"Chronic kidney disease post-liver transplantation.","volume":"21","author":"O\u2019Riordan","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/lt.21682","article-title":"Acute kidney injury following liver transplantation: definition and outcome.","volume":"15","author":"Barri","year":"2009","journal-title":"Liver Transpl"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1478-3231.2009.02182.x","article-title":"The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study.","volume":"30","author":"Trawal\u00e9","year":"2010","journal-title":"Liver Int"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1097\/TP.0b013e3182884890","article-title":"Chronic kidney disease after liver transplantation: pretransplantation risk factors and predictors during follow-up.","volume":"95","author":"Giusto","year":"2013","journal-title":"Transplantation"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/TP.0b013e3182384aff","article-title":"Early changes in kidney function predict long-term chronic kidney disease and mortality in patients after liver transplantation.","volume":"92","author":"Cantarovich","year":"2011","journal-title":"Transplantation"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1053\/jlts.2003.50113","article-title":"Independent risk factors and natural history of renal dysfunction in liver transplant recipients.","volume":"9","author":"Pawarode","year":"2003","journal-title":"Liver Transpl"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/lt.21367","article-title":"Transplantation: impact of pretransplant renal insufficiency.","volume":"14","author":"Bahirwani","year":"2008","journal-title":"Liver Transpl"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/lt.23498","article-title":"Living donor liver transplantation for hepatorenal syndrome: to do or not to do? That is the question.","volume":"18","author":"Nadim","year":"2012","journal-title":"Liver Transpl"},{"key":"R47-20250604","first-page":"164","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis.","volume":"48","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2010.07.043","article-title":"Prognostic importance of the cause of renal failure in patients with cirrhosis.","volume":"140","author":"Mart\u00edn-Llah\u00ed","year":"2011","journal-title":"Gastroenterology"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1523-1755.2005.00408.x","article-title":"Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy.","volume":"68","author":"Wong","year":"2005","journal-title":"Kidney Int"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ndt\/gfi212","article-title":"The course of type 1 hepato-renal syndrome post liver transplantation.","volume":"21","author":"Marik","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R52-20250604","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ki.2014.338","article-title":"Renal dysfunction in cirrhosis is not just a vasomotor nephropathy.","volume":"87","author":"Adebayo","year":"2015","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"R53-20250604","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12072-017-9815-0","article-title":"Management of ascites and hepatorenal syndrome.","volume":"12","author":"Piano","year":"2018","journal-title":"Hepatol Int"},{"key":"R54-20250604","doi-asserted-by":"crossref","first-page":"5362810","DOI":"10.1155\/2018\/5362810","article-title":"Clinical outcomes after liver transplantation for hepatorenal syndrome: a systematic review and meta-analysis.","volume":"2018","author":"Utako","year":"2018","journal-title":"Biomed Res Int"},{"key":"R56-20250604","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document.","volume":"71","author":"Angeli","year":"2019","journal-title":"J Hepatol"},{"key":"R57-20250604","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jhep.2019.09.016","article-title":"Lack of evidence for a continuum between hepatorenal syndrome and acute tubular necrosis.","volume":"72","author":"Sol\u00e9","year":"2020","journal-title":"J Hepatol"},{"key":"R58-20250604","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jhep.2019.12.010","article-title":"Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension.","volume":"72","author":"Garcia-Tsao","year":"2020","journal-title":"J Hepatol"},{"key":"R59-20250604","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/hep.26704","article-title":"Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations.","volume":"59","author":"Francoz","year":"2014","journal-title":"Hepatology"},{"key":"R60-20250604","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/hep.28891","article-title":"Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: the royal free hospital cirrhosis glomerular filtration rate.","volume":"65","author":"Kalafateli","year":"2017","journal-title":"Hepatology"},{"key":"R61-20250604","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13148","article-title":"The liver recipient with acute renal dysfunction: a single institution evaluation of the simultaneous liver-kidney transplant candidate.","volume":"32","author":"Yadav","year":"2018","journal-title":"Clin Transplant"},{"key":"R62-20250604","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MCG.0000000000000818","article-title":"MELD stratified outcomes among recipients with diabetes or hypertension: simultaneous liver kidney versus liver alone.","volume":"52","author":"Singal","year":"2018","journal-title":"J Clin Gastroenterol"},{"key":"R63-20250604","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/hep.29303","article-title":"Significance of oliguria in critically ill patients with chronic liver disease.","volume":"66","author":"Amathieu","year":"2017","journal-title":"Hepatology"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:08:33Z","timestamp":1749064113000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003384","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,29]]}}}